Remission of acute monocytic leukemia, secondary to treatment with epipodophyllotoxins, in a patient with t(8;16)(p11;p13) and MYST3-CREBBP fusion.
Vizmanos
José L
JL
Larráyoz
María J
MJ
Vázquez
Iria
I
Odero
María D
MD
Hernández
Roberto
R
Lahortiga
Idoya
I
Novo
Francisco J
FJ
Ardanaz
María T
MT
Calasanz
María J
MJ
D000328:Adult; D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects*; D016026:Bone Marrow Transplantation; D002871:Chromosome Banding; D002885:Chromosomes, Human, Pair 16 / Q000235:genetics*; D002898:Chromosomes, Human, Pair 8 / Q000235:genetics*; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D007621:Karyotyping; D007948:Leukemia, Monocytic, Acute / Q000139:chemically induced / Q000235:genetics / Q000628:therapy*; D008297:Male; D015514:Oncogene Proteins, Fusion / Q000235:genetics*; D011034:Podophyllotoxin / Q000009:adverse effects*; D012074:Remission Induction; D014178:Translocation, Genetic / Q000235:genetics*
D000972:Antineoplastic Agents, Phytogenic; C470260:MOZ-CBP fusion protein, human; D015514:Oncogene Proteins, Fusion; D011034:Podophyllotoxin